nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Prednisone—systemic scleroderma	0.563	1	CrCtD
Exemestane—Testolactone—Mometasone—systemic scleroderma	0.0467	0.135	CrCrCtD
Exemestane—Prednisone—Mometasone—systemic scleroderma	0.0418	0.121	CrCrCtD
Exemestane—Loteprednol—Mometasone—systemic scleroderma	0.0389	0.113	CrCrCtD
Exemestane—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.0389	0.113	CrCrCtD
Exemestane—Methylprednisolone—Mometasone—systemic scleroderma	0.0363	0.105	CrCrCtD
Exemestane—Prednisolone—Mometasone—systemic scleroderma	0.0356	0.103	CrCrCtD
Exemestane—Testolactone—Prednisone—systemic scleroderma	0.0255	0.0738	CrCrCtD
Exemestane—Loteprednol—Prednisone—systemic scleroderma	0.0212	0.0614	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.0212	0.0614	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—systemic scleroderma	0.0198	0.0574	CrCrCtD
Exemestane—Prednisolone—Prednisone—systemic scleroderma	0.0194	0.0562	CrCrCtD
Exemestane—Myalgia—Lisinopril—systemic scleroderma	0.000114	0.00125	CcSEcCtD
Exemestane—Chest pain—Lisinopril—systemic scleroderma	0.000114	0.00125	CcSEcCtD
Exemestane—Anxiety—Lisinopril—systemic scleroderma	0.000114	0.00125	CcSEcCtD
Exemestane—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.00124	CcSEcCtD
Exemestane—Dyspnoea—Leflunomide—systemic scleroderma	0.000113	0.00124	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000113	0.00124	CcSEcCtD
Exemestane—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000113	0.00124	CcSEcCtD
Exemestane—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000113	0.00123	CcSEcCtD
Exemestane—Dyspepsia—Leflunomide—systemic scleroderma	0.000112	0.00123	CcSEcCtD
Exemestane—Vomiting—Mometasone—systemic scleroderma	0.000112	0.00122	CcSEcCtD
Exemestane—Sweating increased—Prednisone—systemic scleroderma	0.000111	0.00122	CcSEcCtD
Exemestane—Feeling abnormal—Azathioprine—systemic scleroderma	0.000111	0.00122	CcSEcCtD
Exemestane—Rash—Mometasone—systemic scleroderma	0.000111	0.00121	CcSEcCtD
Exemestane—Asthenia—Captopril—systemic scleroderma	0.000111	0.00121	CcSEcCtD
Exemestane—Dermatitis—Mometasone—systemic scleroderma	0.000111	0.00121	CcSEcCtD
Exemestane—Decreased appetite—Leflunomide—systemic scleroderma	0.000111	0.00121	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000111	0.00121	CcSEcCtD
Exemestane—Osteoarthritis—Methotrexate—systemic scleroderma	0.00011	0.00121	CcSEcCtD
Exemestane—Confusional state—Lisinopril—systemic scleroderma	0.00011	0.00121	CcSEcCtD
Exemestane—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00011	0.00121	CcSEcCtD
Exemestane—Headache—Mometasone—systemic scleroderma	0.00011	0.00121	CcSEcCtD
Exemestane—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00011	0.0012	CcSEcCtD
Exemestane—Insomnia—Mycophenolic acid—systemic scleroderma	0.00011	0.0012	CcSEcCtD
Exemestane—Fatigue—Leflunomide—systemic scleroderma	0.00011	0.0012	CcSEcCtD
Exemestane—Oedema—Lisinopril—systemic scleroderma	0.000109	0.0012	CcSEcCtD
Exemestane—Pruritus—Captopril—systemic scleroderma	0.000109	0.0012	CcSEcCtD
Exemestane—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000109	0.00119	CcSEcCtD
Exemestane—Pain—Leflunomide—systemic scleroderma	0.000109	0.00119	CcSEcCtD
Exemestane—Constipation—Leflunomide—systemic scleroderma	0.000109	0.00119	CcSEcCtD
Exemestane—Infection—Lisinopril—systemic scleroderma	0.000109	0.00119	CcSEcCtD
Exemestane—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000108	0.00119	CcSEcCtD
Exemestane—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000107	0.00117	CcSEcCtD
Exemestane—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000107	0.00117	CcSEcCtD
Exemestane—Body temperature increased—Azathioprine—systemic scleroderma	0.000107	0.00117	CcSEcCtD
Exemestane—Abdominal pain—Azathioprine—systemic scleroderma	0.000107	0.00117	CcSEcCtD
Exemestane—Skin disorder—Lisinopril—systemic scleroderma	0.000106	0.00116	CcSEcCtD
Exemestane—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00116	CcSEcCtD
Exemestane—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000106	0.00116	CcSEcCtD
Exemestane—Diarrhoea—Captopril—systemic scleroderma	0.000106	0.00116	CcSEcCtD
Exemestane—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000106	0.00116	CcSEcCtD
Exemestane—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00115	CcSEcCtD
Exemestane—Feeling abnormal—Leflunomide—systemic scleroderma	0.000105	0.00115	CcSEcCtD
Exemestane—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000105	0.00115	CcSEcCtD
Exemestane—Fatigue—Mycophenolic acid—systemic scleroderma	0.000105	0.00115	CcSEcCtD
Exemestane—Nausea—Mometasone—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Anorexia—Lisinopril—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Weight increased—Prednisone—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Pain—Mycophenolic acid—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Constipation—Mycophenolic acid—systemic scleroderma	0.000104	0.00114	CcSEcCtD
Exemestane—Cough—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00112	CcSEcCtD
Exemestane—Dizziness—Captopril—systemic scleroderma	0.000102	0.00112	CcSEcCtD
Exemestane—Depression—Prednisone—systemic scleroderma	0.000102	0.00111	CcSEcCtD
Exemestane—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00111	CcSEcCtD
Exemestane—Urticaria—Leflunomide—systemic scleroderma	0.000101	0.00111	CcSEcCtD
Exemestane—Abdominal pain—Leflunomide—systemic scleroderma	0.000101	0.0011	CcSEcCtD
Exemestane—Body temperature increased—Leflunomide—systemic scleroderma	0.000101	0.0011	CcSEcCtD
Exemestane—Acute coronary syndrome—Prednisone—systemic scleroderma	0.0001	0.0011	CcSEcCtD
Exemestane—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0001	0.0011	CcSEcCtD
Exemestane—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00109	CcSEcCtD
Exemestane—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00109	CcSEcCtD
Exemestane—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00109	CcSEcCtD
Exemestane—Neuropathy peripheral—Prednisone—systemic scleroderma	9.98e-05	0.00109	CcSEcCtD
Exemestane—Myocardial infarction—Prednisone—systemic scleroderma	9.98e-05	0.00109	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	9.96e-05	0.00109	CcSEcCtD
Exemestane—Anxiety—Mycophenolate mofetil—systemic scleroderma	9.96e-05	0.00109	CcSEcCtD
Exemestane—Hypersensitivity—Azathioprine—systemic scleroderma	9.93e-05	0.00109	CcSEcCtD
Exemestane—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	9.93e-05	0.00109	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	9.93e-05	0.00109	CcSEcCtD
Exemestane—Insomnia—Lisinopril—systemic scleroderma	9.89e-05	0.00108	CcSEcCtD
Exemestane—Paraesthesia—Lisinopril—systemic scleroderma	9.82e-05	0.00108	CcSEcCtD
Exemestane—Vomiting—Captopril—systemic scleroderma	9.82e-05	0.00108	CcSEcCtD
Exemestane—Dyspnoea—Lisinopril—systemic scleroderma	9.75e-05	0.00107	CcSEcCtD
Exemestane—Rash—Captopril—systemic scleroderma	9.74e-05	0.00107	CcSEcCtD
Exemestane—Dermatitis—Captopril—systemic scleroderma	9.73e-05	0.00107	CcSEcCtD
Exemestane—Headache—Captopril—systemic scleroderma	9.67e-05	0.00106	CcSEcCtD
Exemestane—Confusional state—Mycophenolate mofetil—systemic scleroderma	9.66e-05	0.00106	CcSEcCtD
Exemestane—Dyspepsia—Lisinopril—systemic scleroderma	9.63e-05	0.00105	CcSEcCtD
Exemestane—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.6e-05	0.00105	CcSEcCtD
Exemestane—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.6e-05	0.00105	CcSEcCtD
Exemestane—Oedema—Mycophenolate mofetil—systemic scleroderma	9.58e-05	0.00105	CcSEcCtD
Exemestane—Infection—Mycophenolate mofetil—systemic scleroderma	9.52e-05	0.00104	CcSEcCtD
Exemestane—Decreased appetite—Lisinopril—systemic scleroderma	9.51e-05	0.00104	CcSEcCtD
Exemestane—Gastrointestinal disorder—Lisinopril—systemic scleroderma	9.44e-05	0.00103	CcSEcCtD
Exemestane—Fatigue—Lisinopril—systemic scleroderma	9.43e-05	0.00103	CcSEcCtD
Exemestane—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	9.4e-05	0.00103	CcSEcCtD
Exemestane—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.38e-05	0.00103	CcSEcCtD
Exemestane—Hypersensitivity—Leflunomide—systemic scleroderma	9.38e-05	0.00103	CcSEcCtD
Exemestane—Pain—Lisinopril—systemic scleroderma	9.35e-05	0.00102	CcSEcCtD
Exemestane—Constipation—Lisinopril—systemic scleroderma	9.35e-05	0.00102	CcSEcCtD
Exemestane—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.31e-05	0.00102	CcSEcCtD
Exemestane—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.26e-05	0.00101	CcSEcCtD
Exemestane—Diarrhoea—Azathioprine—systemic scleroderma	9.22e-05	0.00101	CcSEcCtD
Exemestane—Haemoglobin—Prednisone—systemic scleroderma	9.19e-05	0.00101	CcSEcCtD
Exemestane—Nausea—Captopril—systemic scleroderma	9.17e-05	0.001	CcSEcCtD
Exemestane—Haemorrhage—Prednisone—systemic scleroderma	9.14e-05	0.001	CcSEcCtD
Exemestane—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.13e-05	0.001	CcSEcCtD
Exemestane—Asthenia—Leflunomide—systemic scleroderma	9.13e-05	0.001	CcSEcCtD
Exemestane—Feeling abnormal—Lisinopril—systemic scleroderma	9.01e-05	0.000987	CcSEcCtD
Exemestane—Pruritus—Leflunomide—systemic scleroderma	9.01e-05	0.000986	CcSEcCtD
Exemestane—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.94e-05	0.00098	CcSEcCtD
Exemestane—Dizziness—Azathioprine—systemic scleroderma	8.91e-05	0.000976	CcSEcCtD
Exemestane—Upper respiratory tract infection—Methotrexate—systemic scleroderma	8.87e-05	0.000972	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	8.73e-05	0.000956	CcSEcCtD
Exemestane—Asthenia—Mycophenolic acid—systemic scleroderma	8.71e-05	0.000954	CcSEcCtD
Exemestane—Diarrhoea—Leflunomide—systemic scleroderma	8.71e-05	0.000954	CcSEcCtD
Exemestane—Urticaria—Lisinopril—systemic scleroderma	8.69e-05	0.000952	CcSEcCtD
Exemestane—Insomnia—Mycophenolate mofetil—systemic scleroderma	8.67e-05	0.000949	CcSEcCtD
Exemestane—Abdominal pain—Lisinopril—systemic scleroderma	8.65e-05	0.000947	CcSEcCtD
Exemestane—Body temperature increased—Lisinopril—systemic scleroderma	8.65e-05	0.000947	CcSEcCtD
Exemestane—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	8.6e-05	0.000942	CcSEcCtD
Exemestane—Pruritus—Mycophenolic acid—systemic scleroderma	8.59e-05	0.000941	CcSEcCtD
Exemestane—Vomiting—Azathioprine—systemic scleroderma	8.57e-05	0.000939	CcSEcCtD
Exemestane—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.54e-05	0.000936	CcSEcCtD
Exemestane—Rash—Azathioprine—systemic scleroderma	8.5e-05	0.000931	CcSEcCtD
Exemestane—Dermatitis—Azathioprine—systemic scleroderma	8.49e-05	0.00093	CcSEcCtD
Exemestane—Depression—Methotrexate—systemic scleroderma	8.49e-05	0.00093	CcSEcCtD
Exemestane—Headache—Azathioprine—systemic scleroderma	8.44e-05	0.000925	CcSEcCtD
Exemestane—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.44e-05	0.000924	CcSEcCtD
Exemestane—Dizziness—Leflunomide—systemic scleroderma	8.42e-05	0.000922	CcSEcCtD
Exemestane—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.33e-05	0.000912	CcSEcCtD
Exemestane—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.31e-05	0.00091	CcSEcCtD
Exemestane—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.27e-05	0.000906	CcSEcCtD
Exemestane—Immune system disorder—Prednisone—systemic scleroderma	8.26e-05	0.000905	CcSEcCtD
Exemestane—Constipation—Mycophenolate mofetil—systemic scleroderma	8.19e-05	0.000898	CcSEcCtD
Exemestane—Pain—Mycophenolate mofetil—systemic scleroderma	8.19e-05	0.000898	CcSEcCtD
Exemestane—Sweating—Methotrexate—systemic scleroderma	8.16e-05	0.000894	CcSEcCtD
Exemestane—Vomiting—Leflunomide—systemic scleroderma	8.09e-05	0.000886	CcSEcCtD
Exemestane—Alopecia—Prednisone—systemic scleroderma	8.08e-05	0.000885	CcSEcCtD
Exemestane—Hypersensitivity—Lisinopril—systemic scleroderma	8.06e-05	0.000883	CcSEcCtD
Exemestane—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.05e-05	0.000882	CcSEcCtD
Exemestane—Dizziness—Mycophenolic acid—systemic scleroderma	8.03e-05	0.000879	CcSEcCtD
Exemestane—Rash—Leflunomide—systemic scleroderma	8.03e-05	0.000879	CcSEcCtD
Exemestane—Dermatitis—Leflunomide—systemic scleroderma	8.02e-05	0.000878	CcSEcCtD
Exemestane—Mental disorder—Prednisone—systemic scleroderma	8.01e-05	0.000877	CcSEcCtD
Exemestane—Nausea—Azathioprine—systemic scleroderma	8.01e-05	0.000877	CcSEcCtD
Exemestane—Headache—Leflunomide—systemic scleroderma	7.97e-05	0.000873	CcSEcCtD
Exemestane—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.9e-05	0.000865	CcSEcCtD
Exemestane—Asthenia—Lisinopril—systemic scleroderma	7.85e-05	0.000859	CcSEcCtD
Exemestane—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.84e-05	0.000858	CcSEcCtD
Exemestane—Pruritus—Lisinopril—systemic scleroderma	7.74e-05	0.000848	CcSEcCtD
Exemestane—Vomiting—Mycophenolic acid—systemic scleroderma	7.72e-05	0.000846	CcSEcCtD
Exemestane—Haemoglobin—Methotrexate—systemic scleroderma	7.68e-05	0.000841	CcSEcCtD
Exemestane—Rash—Mycophenolic acid—systemic scleroderma	7.66e-05	0.000839	CcSEcCtD
Exemestane—Dermatitis—Mycophenolic acid—systemic scleroderma	7.65e-05	0.000838	CcSEcCtD
Exemestane—Haemorrhage—Methotrexate—systemic scleroderma	7.64e-05	0.000837	CcSEcCtD
Exemestane—Hepatitis—Methotrexate—systemic scleroderma	7.64e-05	0.000837	CcSEcCtD
Exemestane—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.61e-05	0.000834	CcSEcCtD
Exemestane—Headache—Mycophenolic acid—systemic scleroderma	7.61e-05	0.000833	CcSEcCtD
Exemestane—Pharyngitis—Methotrexate—systemic scleroderma	7.58e-05	0.000831	CcSEcCtD
Exemestane—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.58e-05	0.00083	CcSEcCtD
Exemestane—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.58e-05	0.00083	CcSEcCtD
Exemestane—Nausea—Leflunomide—systemic scleroderma	7.56e-05	0.000828	CcSEcCtD
Exemestane—Diarrhoea—Lisinopril—systemic scleroderma	7.48e-05	0.00082	CcSEcCtD
Exemestane—Visual impairment—Methotrexate—systemic scleroderma	7.36e-05	0.000807	CcSEcCtD
Exemestane—Dizziness—Lisinopril—systemic scleroderma	7.23e-05	0.000792	CcSEcCtD
Exemestane—Erythema multiforme—Methotrexate—systemic scleroderma	7.22e-05	0.000791	CcSEcCtD
Exemestane—Nausea—Mycophenolic acid—systemic scleroderma	7.21e-05	0.00079	CcSEcCtD
Exemestane—Malaise—Prednisone—systemic scleroderma	7.18e-05	0.000786	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—systemic scleroderma	7.09e-05	0.000777	CcSEcCtD
Exemestane—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000773	CcSEcCtD
Exemestane—Vomiting—Lisinopril—systemic scleroderma	6.95e-05	0.000762	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—systemic scleroderma	6.9e-05	0.000756	CcSEcCtD
Exemestane—Rash—Lisinopril—systemic scleroderma	6.9e-05	0.000755	CcSEcCtD
Exemestane—Dermatitis—Lisinopril—systemic scleroderma	6.89e-05	0.000755	CcSEcCtD
Exemestane—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.88e-05	0.000753	CcSEcCtD
Exemestane—Hypertension—Prednisone—systemic scleroderma	6.87e-05	0.000753	CcSEcCtD
Exemestane—Headache—Lisinopril—systemic scleroderma	6.85e-05	0.00075	CcSEcCtD
Exemestane—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.78e-05	0.000743	CcSEcCtD
Exemestane—Myalgia—Prednisone—systemic scleroderma	6.78e-05	0.000742	CcSEcCtD
Exemestane—Arthralgia—Prednisone—systemic scleroderma	6.78e-05	0.000742	CcSEcCtD
Exemestane—Anxiety—Prednisone—systemic scleroderma	6.75e-05	0.00074	CcSEcCtD
Exemestane—Alopecia—Methotrexate—systemic scleroderma	6.75e-05	0.00074	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.73e-05	0.000737	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—systemic scleroderma	6.69e-05	0.000733	CcSEcCtD
Exemestane—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.56e-05	0.000718	CcSEcCtD
Exemestane—Nausea—Lisinopril—systemic scleroderma	6.5e-05	0.000712	CcSEcCtD
Exemestane—Oedema—Prednisone—systemic scleroderma	6.5e-05	0.000711	CcSEcCtD
Exemestane—Infection—Prednisone—systemic scleroderma	6.45e-05	0.000707	CcSEcCtD
Exemestane—Back pain—Methotrexate—systemic scleroderma	6.43e-05	0.000705	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—systemic scleroderma	6.37e-05	0.000698	CcSEcCtD
Exemestane—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.34e-05	0.000694	CcSEcCtD
Exemestane—Skin disorder—Prednisone—systemic scleroderma	6.31e-05	0.000691	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisone—systemic scleroderma	6.28e-05	0.000688	CcSEcCtD
Exemestane—Anorexia—Prednisone—systemic scleroderma	6.19e-05	0.000678	CcSEcCtD
Exemestane—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.09e-05	0.000667	CcSEcCtD
Exemestane—Rash—Mycophenolate mofetil—systemic scleroderma	6.04e-05	0.000662	CcSEcCtD
Exemestane—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.04e-05	0.000661	CcSEcCtD
Exemestane—Headache—Mycophenolate mofetil—systemic scleroderma	6e-05	0.000658	CcSEcCtD
Exemestane—Malaise—Methotrexate—systemic scleroderma	6e-05	0.000657	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—systemic scleroderma	5.95e-05	0.000652	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.92e-05	0.000648	CcSEcCtD
Exemestane—Insomnia—Prednisone—systemic scleroderma	5.87e-05	0.000644	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—systemic scleroderma	5.83e-05	0.000639	CcSEcCtD
Exemestane—Cough—Methotrexate—systemic scleroderma	5.8e-05	0.000636	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—systemic scleroderma	5.72e-05	0.000626	CcSEcCtD
Exemestane—Nausea—Mycophenolate mofetil—systemic scleroderma	5.69e-05	0.000623	CcSEcCtD
Exemestane—Myalgia—Methotrexate—systemic scleroderma	5.66e-05	0.00062	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—systemic scleroderma	5.66e-05	0.00062	CcSEcCtD
Exemestane—Chest pain—Methotrexate—systemic scleroderma	5.66e-05	0.00062	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—systemic scleroderma	5.65e-05	0.000618	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.62e-05	0.000616	CcSEcCtD
Exemestane—Fatigue—Prednisone—systemic scleroderma	5.6e-05	0.000613	CcSEcCtD
Exemestane—Constipation—Prednisone—systemic scleroderma	5.55e-05	0.000608	CcSEcCtD
Exemestane—Confusional state—Methotrexate—systemic scleroderma	5.47e-05	0.0006	CcSEcCtD
Exemestane—Infection—Methotrexate—systemic scleroderma	5.39e-05	0.000591	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—systemic scleroderma	5.35e-05	0.000586	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—systemic scleroderma	5.32e-05	0.000583	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—systemic scleroderma	5.32e-05	0.000582	CcSEcCtD
Exemestane—Gastrointestinal pain—Prednisone—systemic scleroderma	5.31e-05	0.000582	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—systemic scleroderma	5.27e-05	0.000578	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—systemic scleroderma	5.25e-05	0.000575	CcSEcCtD
Exemestane—Anorexia—Methotrexate—systemic scleroderma	5.17e-05	0.000567	CcSEcCtD
Exemestane—Urticaria—Prednisone—systemic scleroderma	5.16e-05	0.000565	CcSEcCtD
Exemestane—Body temperature increased—Prednisone—systemic scleroderma	5.13e-05	0.000562	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—systemic scleroderma	5.13e-05	0.000562	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.95e-05	0.000542	CcSEcCtD
Exemestane—Insomnia—Methotrexate—systemic scleroderma	4.91e-05	0.000538	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—systemic scleroderma	4.87e-05	0.000534	CcSEcCtD
Exemestane—Dyspnoea—Methotrexate—systemic scleroderma	4.84e-05	0.00053	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—systemic scleroderma	4.79e-05	0.000524	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—systemic scleroderma	4.78e-05	0.000523	CcSEcCtD
Exemestane—Decreased appetite—Methotrexate—systemic scleroderma	4.72e-05	0.000517	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.69e-05	0.000513	CcSEcCtD
Exemestane—Fatigue—Methotrexate—systemic scleroderma	4.68e-05	0.000513	CcSEcCtD
Exemestane—Asthenia—Prednisone—systemic scleroderma	4.66e-05	0.00051	CcSEcCtD
Exemestane—Pain—Methotrexate—systemic scleroderma	4.64e-05	0.000508	CcSEcCtD
Exemestane—Pruritus—Prednisone—systemic scleroderma	4.6e-05	0.000503	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—systemic scleroderma	4.47e-05	0.00049	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—systemic scleroderma	4.44e-05	0.000487	CcSEcCtD
Exemestane—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.44e-05	0.000486	CcSEcCtD
Exemestane—Urticaria—Methotrexate—systemic scleroderma	4.31e-05	0.000472	CcSEcCtD
Exemestane—Dizziness—Prednisone—systemic scleroderma	4.3e-05	0.00047	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—systemic scleroderma	4.29e-05	0.00047	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—systemic scleroderma	4.29e-05	0.00047	CcSEcCtD
Exemestane—Vomiting—Prednisone—systemic scleroderma	4.13e-05	0.000452	CcSEcCtD
Exemestane—Rash—Prednisone—systemic scleroderma	4.1e-05	0.000449	CcSEcCtD
Exemestane—Dermatitis—Prednisone—systemic scleroderma	4.09e-05	0.000448	CcSEcCtD
Exemestane—Headache—Prednisone—systemic scleroderma	4.07e-05	0.000446	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—systemic scleroderma	4e-05	0.000438	CcSEcCtD
Exemestane—Asthenia—Methotrexate—systemic scleroderma	3.89e-05	0.000427	CcSEcCtD
Exemestane—Nausea—Prednisone—systemic scleroderma	3.86e-05	0.000423	CcSEcCtD
Exemestane—Pruritus—Methotrexate—systemic scleroderma	3.84e-05	0.000421	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—systemic scleroderma	3.71e-05	0.000407	CcSEcCtD
Exemestane—Dizziness—Methotrexate—systemic scleroderma	3.59e-05	0.000393	CcSEcCtD
Exemestane—Vomiting—Methotrexate—systemic scleroderma	3.45e-05	0.000378	CcSEcCtD
Exemestane—Rash—Methotrexate—systemic scleroderma	3.42e-05	0.000375	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—systemic scleroderma	3.42e-05	0.000375	CcSEcCtD
Exemestane—Headache—Methotrexate—systemic scleroderma	3.4e-05	0.000372	CcSEcCtD
Exemestane—Nausea—Methotrexate—systemic scleroderma	3.22e-05	0.000353	CcSEcCtD
